AFT Pharmaceuticals Limited (NZE:AFT)

Arcadium Lithium Revenue

In the fiscal year ending March 31, 2025, AFT Pharmaceuticals had annual revenue of 208.02M NZD with 6.45% growth. AFT Pharmaceuticals had revenue of 121.31M in the half year ending March 31, 2025, with 33.47% growth.

• Revenue: 208.02M
• Revenue Growth: +6.45%
• P/S Ratio: 1.33
• Revenue / Employee: 1.75M
• Employees: 119
• Market Cap: 276.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	208.02M	12.61M	6.45%
Mar 31, 2024	195.41M	38.77M	24.75%
Mar 31, 2023	156.64M	26.33M	20.20%
Mar 31, 2022	130.31M	17.21M	15.22%
Mar 31, 2021	113.11M	7.51M	7.11%